IHS Chemical Week

Chemical Week Magazine :: Business & Finance :: United States/Americas

Monsanto, Tekmira sign ag biologicals agreement

6:30 AM MST | January 17, 2014 | —Rebecca Coons

Tekmira Pharmaceuticals, a leading developer of RNA interference (RNAi) therapeutics, announced on 13 January that it had signed an option agreement with Monsanto under which the seed giant may obtain a license to use Tekmira’s delivery technology in biopesticides....

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily newsvv and analysis from the entire global chemical enterprise on chemweek.com
  • Free mobile edition of Chemical Week
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional focus
  • Global outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa